Chemoreception: Keeping carbon dioxide in check

The response of the brainstem to increased levels of carbon dioxide in the blood is coordinated with the response of the cardiovascular system.
  1. Alfredo J Garcia III
  2. Jan-Marino Ramirez  Is a corresponding author
  1. University of Chicago, United States
  2. Seattle Children's Research Institute, United States
  3. University of Washington School of Medicine, United States

Changes in the level of carbon dioxide molecules and hydrogen ions in the blood can change its pH, and this can have a negative impact on brain function. To avoid this, mammals rely on specialized cells in the brainstem called central chemoreceptors that can detect changes in the pH of the blood. When these chemoreceptors detect such a change, the body responds by regulating blood flow and breathing. However, changes in the rate at which blood flows through the brain make it more difficult to detect changes in its pH.

The pH of a liquid is determined by the concentration of hydrogen ions in it: the higher the concentration of hydrogen ions, the lower the pH. Carbon dioxide influences the pH of blood by reacting with water to form carbonic acid (H2CO3), which can dissociate to form a hydrogen ion (H+) and a hydrogen carbonate ion (HCO3-). Increasing the concentration of carbon dioxide in the blood therefore results in more H+ ions and a lower pH. However, both these reactions are reversible, and breathing heavily to remove carbon dioxide from the body will lead to a reduction in the concentration of the H+ and HCO3- ions, and hence to an increase in pH.

For over a century, it was thought that all the blood vessels in the brain reacted to increased levels of carbon dioxide in the blood by becoming wider to increase blood flow. Now, in eLife, Daniel Mulkey of the University of Connecticut, Thiago Moreira of the University of Sao Paulo and colleagues – including Virginia Hawkins as first author – report that elevated levels of carbon dioxide (a condition known as hypercapnia) cause the blood vessels in the brainstem to become narrower, while the blood vessels in the rest of the brain become wider (Hawkins et al., 2017).

Although the magnitude of the narrowing observed in the brainstem is modest (the diameter of the arteriole is reduced by less than 10%), the phenomenon reported by Hawkins et al. is reminiscent of the way that a shortage of oxygen (a condition known as hypoxia) causes the small pulmonary arteries in the lung to become narrower. This process optimizes lung function by redirecting of blood flow to areas of the lung where there is little blood flow, thereby increasing the surface area for gas exchange (Ward and McMurtry, 2009). Similarly, the narrowing of the blood vessels in the brainstem caused by increased levels of carbon dioxide might, according to Hawkins et al., help the body to measure the levels of carbon dioxide and H+ ions in the blood more accurately.

While neurons throughout the brainstem are known to be involved in the detection of carbon dioxide and H+ ions (Guyenet et al., 2010), the neurons in two regions of the brainstem – the ventrolateral medulla and the retrotrapezoid nucleus – have a particularly significant role (Kumar et al., 2015). However, the discovery in 2010 that astrocytes (cells in the brain and spinal cord that are not neurons) were also involved in central chemoreception showed that the regulation of breathing was more complex than expected (Gourine et al., 2010). The results of the elegant study by Hawkins et al. are further evidence in support of such complexity.

These are exciting times for the field. For over a half of a century, the drive to understand central chemosensitivity has understandably been focused on the cellular and molecular substrates of the phenomenon. However, growing evidence supports the notion that central chemosensitivity is a property that emerges from concerted interactions across the multiple cell types in the neurovascular unit, and that physiological interactions have an important role. While the phenomenon reported by Hawkins et al. appears to be small in magnitude, its potential impact on physiology cannot be dismissed.

Further research is now needed to address a number of questions: Does the constriction of the blood vessels seen by Hawkins et al. influence the pH of the surrounding tissue? Does the constriction have an impact on the cellular physiology of the neurons and astrocytes in the neurovascular unit? And how do the blood vessels in other regions of the brainstem respond to high levels of carbon dioxide? Answering these questions could, ultimately, lead to a systems-level understanding of the mechanisms underlying central chemosensitivity, and thus provide insights into the variability of this process in both health and disease.

References

Article and author information

Author details

  1. Alfredo J Garcia III

    Institute for Integrative Physiology and the Section of Emergency Medicine, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5620-7519
  2. Jan-Marino Ramirez

    1. Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, United States
    2. Department of Neurological Surgery, University of Washington School of Medicine, Seattle, United States
    For correspondence
    jan.ramirez@seattlechildrens.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5626-3999

Publication history

  1. Version of Record published: May 17, 2017 (version 1)

Copyright

© 2017, Garcia et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,401
    views
  • 126
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alfredo J Garcia III
  2. Jan-Marino Ramirez
(2017)
Chemoreception: Keeping carbon dioxide in check
eLife 6:e27563.
https://doi.org/10.7554/eLife.27563

Further reading

    1. Neuroscience
    Olujolagbe Layinka, Luca D Hargitai ... Florence YN Leung
    Feature Article

    Improving our understanding of autism, ADHD, dyslexia and other neurodevelopmental conditions requires collaborations between genetics, psychiatry, the social sciences and other fields of research.

    1. Genetics and Genomics
    2. Neuroscience
    Bohan Zhu, Richard I Ainsworth ... Javier González-Maeso
    Research Article

    Genome-wide association studies have revealed >270 loci associated with schizophrenia risk, yet these genetic factors do not seem to be sufficient to fully explain the molecular determinants behind this psychiatric condition. Epigenetic marks such as post-translational histone modifications remain largely plastic during development and adulthood, allowing a dynamic impact of environmental factors, including antipsychotic medications, on access to genes and regulatory elements. However, few studies so far have profiled cell-specific genome-wide histone modifications in postmortem brain samples from schizophrenia subjects, or the effect of antipsychotic treatment on such epigenetic marks. Here, we conducted ChIP-seq analyses focusing on histone marks indicative of active enhancers (H3K27ac) and active promoters (H3K4me3), alongside RNA-seq, using frontal cortex samples from antipsychotic-free (AF) and antipsychotic-treated (AT) individuals with schizophrenia, as well as individually matched controls (n=58). Schizophrenia subjects exhibited thousands of neuronal and non-neuronal epigenetic differences at regions that included several susceptibility genetic loci, such as NRG1, DISC1, and DRD3. By analyzing the AF and AT cohorts separately, we identified schizophrenia-associated alterations in specific transcription factors, their regulatees, and epigenomic and transcriptomic features that were reversed by antipsychotic treatment; as well as those that represented a consequence of antipsychotic medication rather than a hallmark of schizophrenia in postmortem human brain samples. Notably, we also found that the effect of age on epigenomic landscapes was more pronounced in frontal cortex of AT-schizophrenics, as compared to AF-schizophrenics and controls. Together, these data provide important evidence of epigenetic alterations in the frontal cortex of individuals with schizophrenia, and remark for the first time on the impact of age and antipsychotic treatment on chromatin organization.